These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31241916)

  • 1. Parallel-Reaction-Monitoring-Based Proteome-Wide Profiling of Differential Kinase Protein Expression during Prostate Cancer Metastasis in Vitro.
    Miao W; Yuan J; Li L; Wang Y
    Anal Chem; 2019 Aug; 91(15):9893-9900. PubMed ID: 31241916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer Metastasis.
    Miao W; Wang Y
    J Proteome Res; 2019 May; 18(5):2279-2286. PubMed ID: 30908912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Kinase Expression Related to Increased Migration of PC-3M Cells Using Global Comparative Phosphoproteome Analysis.
    Gao Y; Ha YS; Kwon TG; Cho YC; Lee S; Lee JN
    Cancer Genomics Proteomics; 2020; 17(5):543-553. PubMed ID: 32859632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic analysis of human prostate cancer PC-3M-1E8 cells and PC-3M-2B4 cells of same origin but with different metastatic potential.
    Zhang S; Zheng C; Yao S; Wang Z; Xu L; Yang R; Meng X; Wu J; Zhou L; Sun Z
    PLoS One; 2018; 13(10):e0206139. PubMed ID: 30379883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin inhibits prostate cancer cells metastasis by reducing matrix metalloproteinase-2/-9 expression via AKT/mTOR and ROS/ERK1/2 pathways.
    Chen Y; Zheng L; Liu J; Zhou Z; Cao X; Lv X; Chen F
    Int Immunopharmacol; 2014 Aug; 21(2):447-55. PubMed ID: 24905636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
    Yan Y; Zhou B; Qian C; Vasquez A; Kamra M; Chatterjee A; Lee YJ; Yuan X; Ellis L; Di Vizio D; Posadas EM; Kyprianou N; Knudsen BS; Shah K; Murali R; Gertych A; You S; Freeman MR; Yang W
    Nat Commun; 2022 Feb; 13(1):669. PubMed ID: 35115556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maclurin exerts anti-cancer effects on PC3 human prostate cancer cells via activation of p38 and inhibitions of JNK, FAK, AKT, and c-Myc signaling pathways.
    Lee YJ; Jung O; Lee J; Son J; Cho JY; Ryou C; Lee SY
    Nutr Res; 2018 Oct; 58():62-71. PubMed ID: 30340816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis.
    Miao W; Li L; Liu X; Qi TF; Guo L; Huang M; Wang Y
    Sci Rep; 2020 Feb; 10(1):2485. PubMed ID: 32051510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiles of androgen independent bone metastatic prostate cancer cells indicate up-regulation of the putative serine-threonine kinase GS3955.
    Bisoffi M; Klima I; Gresko E; Durfee PN; Hines WC; Griffith JK; Studer UE; Thalmann GN
    J Urol; 2004 Sep; 172(3):1145-50. PubMed ID: 15311059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HGK promotes metastatic dissemination in prostate cancer.
    Garcia-Garcia S; Rodrigo-Faus M; Fonseca N; Manzano S; Győrffy B; Ocaña A; Bragado P; Porras A; Gutierrez-Uzquiza A
    Sci Rep; 2021 Jun; 11(1):12287. PubMed ID: 34112843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell fate regulation by reticulon-4 in human prostate cancers.
    Zhao H; Su W; Zhu C; Zeng T; Yang S; Wu W; Wang D
    J Cell Physiol; 2019 Jul; 234(7):10372-10385. PubMed ID: 30480803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBM4-SRSF3-MAP4K4 splicing cascade modulates the metastatic signature of colorectal cancer cell.
    Lin JC; Lee YC; Tan TH; Liang YC; Chuang HC; Fann YC; Johnson KR; Lin YJ
    Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):259-272. PubMed ID: 29138007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.
    Wang Z; Li Y; Banerjee S; Kong D; Ahmad A; Nogueira V; Hay N; Sarkar FH
    J Cell Biochem; 2010 Mar; 109(4):726-36. PubMed ID: 20052673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways.
    Majumder PK; Febbo PG; Bikoff R; Berger R; Xue Q; McMahon LM; Manola J; Brugarolas J; McDonnell TJ; Golub TR; Loda M; Lane HA; Sellers WR
    Nat Med; 2004 Jun; 10(6):594-601. PubMed ID: 15156201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional screen identifies kinases driving prostate cancer visceral and bone metastasis.
    Faltermeier CM; Drake JM; Clark PM; Smith BA; Zong Y; Volpe C; Mathis C; Morrissey C; Castor B; Huang J; Witte ON
    Proc Natl Acad Sci U S A; 2016 Jan; 113(2):E172-81. PubMed ID: 26621741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
    Kim SJ; Johnson M; Koterba K; Herynk MH; Uehara H; Gallick GE
    Clin Cancer Res; 2003 Nov; 9(14):5161-70. PubMed ID: 14613995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
    Xu L; Chen S; Bergan RC
    Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.
    Wei J; Xu G; Wu M; Zhang Y; Li Q; Liu P; Zhu T; Song A; Zhao L; Han Z; Chen G; Wang S; Meng L; Zhou J; Lu Y; Wang S; Ma D
    Anticancer Res; 2008; 28(1A):327-34. PubMed ID: 18383865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics.
    Kwon OK; Jeon JM; Sung E; Na AY; Kim SJ; Lee S
    Cancer Genomics Proteomics; 2018; 15(4):279-290. PubMed ID: 29976633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
    Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
    Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.